Company Profile
FEMASYS Stock Price, News & Analysis
- Ticker:
- FEMY
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
2.95 USD (-1.99%)
Close
Last updated: August 6, 2026
22.4M USD
Market cap
Why the stock is moving
The latest monitored company update is “Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million.” The corresponding closing-price reaction is not yet available.
Company overview
Business overview
Femasys is a women’s health medical technology company focused on fertility and reproductive-health products. Its business is centered on procedures and devices that address unmet needs in women’s health.
Geographic Base and Sector Classification
Femasys is headquartered in the United States and listed on NASDAQ. It sits in women’s-health medtech rather than biotechnology.
Business Model Characteristics
The company depends on product adoption, physician acceptance, and regulatory or commercial milestones. Investors watch launch execution, reimbursement, and the pace of market penetration.
Position Within the Biotechnology Landscape
Femasys occupies a women’s-health device niche within healthcare innovation. It is not biotech proper, but its growth still depends on product adoption and clinical credibility.
Future catalysts
Femasys’s catalysts are FemBloc commercialization and women’s-health product development, where adoption and regulatory progress matter most. The company needs to show the platform can translate into real clinical use.
Recent news
- 01
- 02
Femasys Regains Compliance with Nasdaq Listing Requirements
Source: FEMASYS
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of FEMASYS (FEMY)?
FEMASYS (FEMY) most recently closed at 2.95 USD, a -1.99% move versus the previous session.
What is the market cap of FEMASYS (FEMY)?
FEMASYS currently has a market capitalization of 22.4M USD on BioPharmSignal.
What does FEMASYS do?
Femasys is a women’s health medical technology company focused on fertility and reproductive-health products. Its business is centered on procedures and devices that address unmet needs in women’s health.
On which exchange is FEMY stock listed?
FEMASYS (FEMY) is associated with NASDAQ, United States, Biopharma.
What is Femasys?
Femasys’s catalysts are FemBloc commercialization and women’s-health product development, where adoption and regulatory progress matter most.
Which conditions is FEMASYS targeting with Femasys?
Femasys’s catalysts are FemBloc commercialization and women’s-health product development, where adoption and regulatory progress matter most.
How does FEMASYS describe recent progress with Femasys?
Femasys’s catalysts are FemBloc commercialization and women’s-health product development, where adoption and regulatory progress matter most.
What is FemBloc?
Femasys’s catalysts are FemBloc commercialization and women’s-health product development, where adoption and regulatory progress matter most.